Publications by authors named "Wolfram Brugger"

44Publications

[What opportunities does Immuno-oncology indicate for overarching long-term survival?].

Oncol Res Treat 2015 28;38 Suppl 3:6-11. Epub 2015 Apr 28.

Medizinische Klinik II: Hämatologie/Onkologie, Universitätsklinikum Frankfurt, Frankfurt/M., Deutschland.

View Article and Find Full Text PDF
February 2016

Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2).

Ann Hematol 2015 Jun 30;94(6):1057-60. Epub 2014 Dec 30.

Department of Hematology and Oncology, Schwarzwald-Baar Clinic, Academic Teaching Hospital University of Freiburg, Klinikstr. 11, 78052, Villingen-Schwenningen, Germany,

View Article and Find Full Text PDF
June 2015

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study.

Lung Cancer 2013 Nov 7;82(2):231-7. Epub 2013 Aug 7.

Service de Pneumologie, Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse III (Paul Sabatier), Toulouse 31059, France. Electronic address:

View Article and Find Full Text PDF
November 2013

Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management.

Oncologist 2013 30;18(8):954-64. Epub 2013 Jul 30.

Department of Hematology, Oncology, and Palliative Care, Schwarzwald-Baar Clinic, Academic Teaching Hospital, University of Freiburg, Villingen-Schwenningen, Germany.

View Article and Find Full Text PDF
May 2014

Molecular marker analyses from the SATURN trial.

Authors:
Wolfram Brugger

Clin Adv Hematol Oncol 2012 Jan;10(1):33-4

Schwarzwald-Baar Klinikum, Academic Teaching Hospital, University of Freiburg, Villingen-Schwenningen, Germany.

View Article and Find Full Text PDF
January 2012

EGFR-TKI resistant non-small cell lung cancer (NSCLC): new developments and implications for future treatment.

Lung Cancer 2012 Jul 24;77(1):2-8. Epub 2012 Jan 24.

Medical Center II, Department of Hematology/Oncology, Schwarzwald-Baar Clinic, Academic Teaching Hospital University of Freiburg, Villingen-Schwenningen, Germany.

View Article and Find Full Text PDF
July 2012

Successful treatment with the fully human antibody panitumumab after a severe infusion reaction with cetuximab.

Authors:
Wolfram Brugger

Tumori 2010 May-Jun;96(3):473-7

Schwarzwald-Baar Clinic, Villingen-Schwenningen, Teaching Hospital, University of Freiburg, Germany.

View Article and Find Full Text PDF
September 2010

Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors.

J Cancer Res Clin Oncol 2010 Dec 9;136(12):1921-7. Epub 2010 Mar 9.

Department of Internal Medicine II, Division of Hematology and Oncology, Immunology, and Rheumatology, University of Tübingen, Tübingen, Germany.

View Article and Find Full Text PDF
December 2010

Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximab.

Eur J Haematol 2010 Jun 22;84(6):547-9. Epub 2010 Jan 22.

Medical Center, Department of Hematology-Oncology, Schwarzwald-Baar Clinic, Academic Teaching Hospital, University of Freiburg, Villingen-Schwenningen, Germany.

View Article and Find Full Text PDF
June 2010

Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disorders.

Hematol J 2004 ;5(5):444-6

Department of Hematology, Oncology and Immunology, University of Tübingen, Medical Center, Otfried-Müller-Strasse 10, D-72076 Tübingen, Germany.

View Article and Find Full Text PDF
March 2005

Clearing minimal residual disease with rituximab consolidation therapy.

Authors:
Wolfram Brugger

Semin Oncol 2004 Feb;31(1 Suppl 2):33-7

Department of Hematology, Oncology, and Immunology, University of Tübingen, Tübingen, Germany.

View Article and Find Full Text PDF
February 2004

Clearing Minimal Residual Disease with Rituximab Consolidation Therapy.

Authors:
Wolfram Brugger

Semin Oncol 2004 Feb;31 Suppl 2:33-37

Department of Hematology, Oncology, and Immunology, University of Tübingen, Tübingen, Germany.

View Article and Find Full Text PDF
February 2004

Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.

Haematologica 2003 Oct;88(10):1139-49

Department of Hematology, Oncology, Immunology and Rheumatology, University of Tübingen, Tübingen, Germany.

View Article and Find Full Text PDF
October 2003

Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells.

Haematologica 2003 Feb;88(2):126-33

Department of Internal Medicine II, Division of Hematology and Oncology, University of Tübingen, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.

View Article and Find Full Text PDF
February 2003

Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma.

J Immunol 2002 Aug;169(3):1228-35

Department of Hematology, Oncology, and Immunology, University of Tübingen, Tübingen, Germany.

View Article and Find Full Text PDF
August 2002

Improving outcomes in transplantation.

Authors:
Wolfram Brugger

Semin Oncol 2002 Apr;29(2 Suppl 6):23-6

Eberhard-Karls Universität, Hämatologie und Onkologie, Medizinische Klinik II, Tübingen, Germany.

View Article and Find Full Text PDF
April 2002